These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Treatment of acute lymphoblastic leukemia in children. Long-term results of two trials. Cáp J; Koza I; Misíková Z; Foltinová A; Strbáková E Neoplasma; 1983; 30(1):81-92. PubMed ID: 6339961 [TBL] [Abstract][Full Text] [Related]
6. [Argentinian Group for the Treatment of Acute Leukemia: our experience in the treatment of acute lymphoblastic leukemias]. Pavlovsky S Sangre (Barc); 1981; 26(5B):845-54. PubMed ID: 7034244 [No Abstract] [Full Text] [Related]
8. Levamisole in chronic lymphocytic leukaemia: a prospective study of 15 patients. Aymard JP; Janot C; Thibaut G; Bertrand F; Legras B; Lederlin P; Streiff F Acta Haematol; 1984; 71(5):316-21. PubMed ID: 6429997 [TBL] [Abstract][Full Text] [Related]
9. Immunotherapy in acute leukemias. Possible applications in children. Mahoney DH; Starling KA Am J Pediatr Hematol Oncol; 1981; 3(4):410-8. PubMed ID: 7036781 [TBL] [Abstract][Full Text] [Related]
10. Medical Research Council leukaemia trial--UKALL V: an attempt to reduce the immunosuppressive effects of therapy in childhood acute lymphoblastic leukemia. Report to the Council by the Working Party on Leukaemia in Childhood. Chessells JM; Durrant J; Hardy RM; Richards S J Clin Oncol; 1986 Dec; 4(12):1758-64. PubMed ID: 3537216 [TBL] [Abstract][Full Text] [Related]
11. Partial normalization of B-cell function by levamisole in acute lymphoblastic leukemia. Díez RA; Estévez ME; Sen L Medicina (B Aires); 1981; 41(4):471-5. PubMed ID: 6978454 [No Abstract] [Full Text] [Related]
12. Levamisole and in vitro PHA-transformation of lymphocytes from acute leukemia patients. Conesa LC; Garay G; Pavlovsky S Cell Mol Biol Incl Cyto Enzymol; 1979; 24(4):331-5. PubMed ID: 291491 [No Abstract] [Full Text] [Related]
14. [Acute lymphoblastic leukemia in children. Long survivals obtained with protocols C2-72 and D-74 (1972-1977)]. Ortega JJ; Javier G; Montagut JM; Torán N An Esp Pediatr; 1986 Feb; 24(2):87-97. PubMed ID: 3516041 [TBL] [Abstract][Full Text] [Related]
15. Use of levamisole in maintaining remission in steroid-sensitive nephrotic syndrome in children. Dayal U; Dayal AK; Shastry JC; Raghupathy P Nephron; 1994; 66(4):408-12. PubMed ID: 8015643 [TBL] [Abstract][Full Text] [Related]
16. Levamisole in steroid-sensitive nephrotic syndrome children with frequent relapses and/or steroid dependency: comparison of daily and every-other-day usage. Fu LS; Shien CY; Chi CS Nephron Clin Pract; 2004; 97(4):c137-41. PubMed ID: 15331936 [TBL] [Abstract][Full Text] [Related]
17. [Cellular and humoral indicators of the immunomodulating effect of levamisole in patients with lymphocytic leukemia]. Tretiak NN; Koval' AI; Minchenko ZhN; Sverstiuk AE Vrach Delo; 1985 Dec; (12):58-61. PubMed ID: 3879409 [No Abstract] [Full Text] [Related]
18. Controlled therapeutic trial of levamisole and sulphasalazine in acute ulcerative colitis. Hermanowicz A; Nowak A; Gajos L Gut; 1984 May; 25(5):S34-8. PubMed ID: 6143709 [TBL] [Abstract][Full Text] [Related]
19. Levamisole in Crohn's disease: a randomized, double-blind, placebo-controlled clinical trial. Sachar DB; Rubin KP; Gumaste V Am J Gastroenterol; 1987 Jun; 82(6):536-9. PubMed ID: 3554991 [TBL] [Abstract][Full Text] [Related]
20. Chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisone alone or with levamisole or with levamisole plus BCG for malignant lymphoma: a Southwest Oncology Group Study. Jones SE; Grozea PN; Miller TP; Van Slyck EJ; Balcerzak SP; Costanzi JJ; Morrison FS; Eyre HJ; Fabian CJ; Dabich L J Clin Oncol; 1985 Oct; 3(10):1318-24. PubMed ID: 3900301 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]